• Today
    May 31

  • 04:04 PM

Johnson & Johnson to continue selling baby powder in UK


Added 21 May 2020


London – Healthcare giant Johnson & Johnson says it will continue to sell its talc-based Johnson's Baby Powder in the UK and the rest of the world, despite stopping sales in the US and Canada.

It said North American sales had shrunk partly because of a “constant barrage” of advertising by lawyers seeking clients to claim against the company.

J&J has been at the centre of claims for years that its talc causes cancer.

It has always strenuously defended the product's safety.

Johnson & Johnson has been ordered to pay out billions of dollars in compensation, but has so far always successfully appealed against these verdicts.

Almost 20 000 people in the US have so far lodged claims against the company.

Talc is mined from the earth and is found in seams close to that of asbestos, a material known to cause cancer.

The company said in a statement: "Johnson & Johnson remains steadfastly confident in the safety of talc-based Johnson's Baby Powder."

It said "decades" of study by medical and legal experts around the world supported its view, and all verdicts against the company that had gone against it had been overturned on appeal.

Dampened demand

It will continue to sell its talc-based products in the US and Canada until stocks have sold out.

It also sells a cornstarch-based powder that it will continue to sell in North America.

It said both types of Johnson's baby powder, talc-based and cornstarch-based, will continue to be sold in other markets around the world where there is "significantly higher" consumer demand for the product.

The firm said changes in consumer behaviour had also dampened demand for the powder.

The firm added that the move was also part of a reassessment of its consumer products prompted by the novel coronavirus (COVID-19) pandemic.

It said in October that its testing had found no asbestos in its baby powder after tests conducted by the US Food and Drug Administratio discovered trace amounts. 

The firm is appealing against a 2018 order to pay $4.7bn (£3.6bn) in damages to 22 women who alleged that its talc products caused them to develop ovarian cancer. (BBC)


Dos and Donts

Welcome to our discussion forum here on nationnews.com. We encourage lively debate, but we also urge you to take note of the following:

  • Stay on topic – This helps keep the thread focused on the discussion at hand. If you would like to discuss another topic, look for a relevant article.
  • Be respectful – Meeting differences of opinion with civil discussion encourages multiple perspectives and a positive commenting environment.
  • Do not type in capitals – In addition to being considered “shouting” it is also difficult to read.
  • All comments will be moderated – Given the volume of comments each day, this may take some time. So please be patient.
  • We reserve the right to remove comments – Comments that we find to be abusive, spam, libellous, hateful, off-topic or harassing may be removed.
  • Reproduction of comments – Some of your comments may be reproduced on the website or in our daily newspapers. We will use the handle, not your email address.
  • Do not advertise – Please contact our Advertising Department.
  • Contact our Online Editor if you have questions or concerns.
  • Read our full Commenting Policy and Terms of Use.
comments powered by Disqus


Are you satisfied with the way the Government of Barbados has handled the COVID-19 public health crisis here?